Sumitomo Mitsui Trust Holdings Inc. Increases Stock Position in Encompass Health Co. (NYSE:EHC)

Sumitomo Mitsui Trust Holdings Inc. lifted its position in Encompass Health Co. (NYSE:EHC - Free Report) by 2.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,318,784 shares of the company's stock after acquiring an additional 29,926 shares during the quarter. Sumitomo Mitsui Trust Holdings Inc. owned approximately 1.32% of Encompass Health worth $87,989,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in EHC. McGlone Suttner Wealth Management Inc. purchased a new stake in shares of Encompass Health in the fourth quarter worth about $30,000. C M Bidwell & Associates Ltd. purchased a new position in Encompass Health during the third quarter valued at $35,000. Worth Asset Management LLC purchased a new position in shares of Encompass Health in the 1st quarter worth about $35,000. Belpointe Asset Management LLC increased its holdings in Encompass Health by 88.2% in the 1st quarter. Belpointe Asset Management LLC now owns 781 shares of the company's stock worth $42,000 after buying an additional 366 shares in the last quarter. Finally, Quarry LP bought a new stake in shares of Encompass Health during the 1st quarter valued at about $42,000. Institutional investors own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on EHC shares. Truist Financial boosted their price target on Encompass Health from $82.00 to $86.00 and gave the stock a "buy" rating in a report on Friday, February 9th. Mizuho raised their price objective on Encompass Health from $77.00 to $82.00 and gave the company a "buy" rating in a research report on Friday, February 9th. Barclays raised their price objective on Encompass Health from $95.00 to $101.00 and gave the company an "overweight" rating in a research report on Thursday, March 28th. William Blair reissued an "outperform" rating on shares of Encompass Health in a report on Wednesday, February 7th. Finally, Stephens reissued an "overweight" rating and issued a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Eight research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Buy" and a consensus target price of $83.22.

Encompass Health Trading Down 1.3 %

Shares of Encompass Health stock traded down $1.05 during trading hours on Thursday, hitting $78.64. The company's stock had a trading volume of 769,242 shares, compared to its average volume of 653,306. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.28 and a current ratio of 1.28. The stock has a market cap of $7.88 billion, a price-to-earnings ratio of 22.66, a P/E/G ratio of 1.48 and a beta of 0.94. Encompass Health Co. has a twelve month low of $57.55 and a twelve month high of $83.73. The firm has a fifty day moving average of $77.26 and a 200-day moving average of $70.22.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $0.12. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The firm had revenue of $1.25 billion for the quarter, compared to the consensus estimate of $1.24 billion. Research analysts forecast that Encompass Health Co. will post 3.96 EPS for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, March 28th. This represents a $0.60 annualized dividend and a yield of 0.76%. Encompass Health's dividend payout ratio (DPR) is 17.29%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.